| Metric | Q3 2024 | Q2 2024 | Q3 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $36M | — | — | — | — |
| Op. Income | $29M | — | — | — | — |
| Gross Margin | 89.3% | — | — | — | — |
| Net Margin | 71.2% | — | — | — | — |
| EPS (Diluted) | $0.36 | — | — | — | — |
| Free Cash Flow | $9M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $36M |
| Cost of Revenue | $4M |
| GROSS PROFIT | $32M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $16M |
| SG&A Expenses | $16M |
| Other Expenses | -$13M |
| Operating Expenses | $3M |
| Cost & Expenses | $7M |
| OPERATING INCOME | $29M |
| Interest Income | $2M |
| Interest Expense | $3M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $26M |
| Income Tax Expense | $81.6K |
| Net Income from Continuing Ops | $26M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $26M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $26M |
| D&A | $0 |
| EBIT | $29M |
| EBITDA | $0 |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $36M |
| Cost of Revenue | $4M |
| GROSS PROFIT | $32M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $16M |
| SG&A Expenses | $16M |
| Other Expenses | -$13M |
| Operating Expenses | $3M |
| Cost & Expenses | $7M |
| OPERATING INCOME | $29M |
| Interest Income | $2M |
| Interest Expense | $3M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $26M |
| Income Tax Expense | $81.6K |
| Net Income from Continuing Ops | $26M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $26M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $26M |
| D&A | $0 |
| EBIT | $29M |
| EBITDA | $0 |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $24M |
| Depreciation & Amortization | $874.1K |
| Stock-Based Compensation | $256.6K |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$7M |
| Change in Working Capital | -$7M |
| OPERATING CASH FLOW | $10M |
| Capital Expenditure | -$914.3K |
| Acquisitions (Net) | $1.2K |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $131.0K |
| Other Investing Activities | $7M |
| NET CASH FROM INVESTING | $7M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$18.8K |
| Common Dividends Paid | -$35M |
| Other Financing Activities | -$14M |
| NET CASH FROM FINANCING | -$49M |
| FREE CASH FLOW | $9M |
| Net Change in Cash | -$98M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $78M |
| Short-Term Investments | $993M |
| Net Receivables | $3M |
| Inventory | $2.6B |
| Other Current Assets | $2.3B |
| TOTAL CURRENT ASSETS | $5.9B |
| PP&E (Net) | $5M |
| Goodwill | $5M |
| Intangible Assets | $16M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $39M |
| TOTAL NON-CURRENT ASSETS | $64M |
| TOTAL ASSETS | $6.0B |
| Account Payables | $2M |
| Short-Term Debt | $40M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $5.4B |
| TOTAL CURRENT LIABILITIES | $5.5B |
| Long-Term Debt | $36M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $39M |
| TOTAL LIABILITIES | $5.5B |
| Common Stock | $59.5K |
| Additional Paid-In Capital | $54M |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $428M |
| TOTAL STOCKHOLDERS' EQUITY | $482M |
| Minority Interest | $0 |
| TOTAL EQUITY | $482M |
| TOTAL LIABILITIES & EQUITY | $6.0B |
| Total Debt | $80M |
| Net Debt | $2M |
